Induction of apoptosis in tumor cells using ligands such as TNF-α, Fas ligand (FasL), TNF–related apoptosis inducing ligands (TRAIL) is an interesting therapeutic approach; however, toxicity and short circulation half-life after systemic administration limits this approach. Here, TNFSF10 is linked to neoplasm.